We are live on ! Find out more
CDTX

Cidara Therapeutics

Delisted

CDTX was delisted on the 6th of January, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
BI
1
BVF Inc
California
$6.83M +$3.48M +48,700 +50%
BB
2
BB Biotech
Switzerland
$5.39M
OFM
3
Omega Fund Management
Massachusetts
$3.55M
IVM
4
InterWest Venture Management
California
$3.19M
FM
5
Frazier Management
Washington
$3.08M
OM
6
Opaleye Management
Massachusetts
$2.82M
AC
7
Aisling Capital
New York
$2.4M
Vanguard Group
8
Vanguard Group
Pennsylvania
$2.03M +$732K +10,263 +31%
ACM
9
Alethea Capital Management
Washington
$1.13M +$161K +2,250 +10%
MIM
10
Monashee Investment Management
Massachusetts
$1.13M +$1.72M +24,043 New
GIM
11
Granahan Investment Management
Massachusetts
$1.11M -$30K -421 -2%
RJA
12
Raymond James & Associates
Florida
$779K +$327K +4,578 +38%
Renaissance Technologies
13
Renaissance Technologies
New York
$744K +$24.3K +340 +2%
BlackRock
14
BlackRock
New York
$685K +$19.9K +279 +2%
FI
15
Fosun International
China
$659K
RJFSA
16
Raymond James Financial Services Advisors
Florida
$634K +$205K +2,866 +27%
PM
17
Prosight Management
Texas
$578K -$282K -3,957 -24%
DCM
18
DAFNA Capital Management
California
$500K
Millennium Management
19
Millennium Management
New York
$495K -$807K -11,312 -52%
WFI
20
West Family Investments
California
$470K
TCM
21
Tekla Capital Management
Massachusetts
$373K
Invesco
22
Invesco
Georgia
$356K -$1.5K -21 -0.3%
JP Morgan Chase
23
JP Morgan Chase
New York
$300K -$75.7K -1,061 -14%
OAM
24
Oxford Asset Management
United Kingdom
$290K +$150K +2,104 +52%
Jacobs Levy Equity Management
25
Jacobs Levy Equity Management
New Jersey
$286K +$10.3K +145 +2%